BY 963

contains a phospholipid derived from soybean lecithins as its active ingredient; a white powder; MF C42-H82-O10; MW 801.1 g/mol

Also Known As:

BY-963; BY963

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Coronary Disease (Coronary Heart Disease) 03/01/2000 - "In 48 consecutive patients (mean age 62 +/- 9 years, 32 males, 16 females) with suspected coronary disease undergoing coronary angiography, the transpulmonary contrast agent BY 963 was given i.v. as bolus during dobutamine stress echocardiography (10-40 micrograms kg min, plus max. "
2.	Body Weight (Weight, Body) 07/01/1998 - "BY963 filled with perfluoropentane (0.2 ml/kg body weight) was injected three times with a time interval between injections of 5 minutes. "

1.	Dobutamine
2.	Contrast Media
3.	perfluoropentane (perflenapent)

1.	Injections